Mayaro Virus Emergence and Genetic Dynamics, Peru

Evidence Dossier: Mayaro Virus Emergence and Genetic Dynamics in Peru Source: Emerging Infectious Diseases Journal, October 2026 What is established Mayaro virus (MAYV) is a neglected zoonotic alphavirus endemic to Latin America and the Caribbean, transmitted primarily by Haemagogus janthinomys mosquitoes among nonhuman primates, with periodic spillover to humans. MAYV infection causes…

Natural Occurrence of Primate SLAM-Adapted Canine Distemper Virus, Brazil, 2018

Evidence Dossier: Primate SLAM-Adapted Canine Distemper Virus in Brazil, 2018 What is established Canine distemper virus (CDV) is a morbillivirus primarily infecting carnivores such as dogs. It can cause severe disease including encephalitis. CDV normally uses the signaling lymphocytic activation molecule (SLAM) receptor to enter host immune cells, and this receptor shows…

Oropouche Fever Outbreak, Havana, Cuba, June–September 2024

Oropouche Fever Outbreak in Havana, Cuba, June–September 2024: Evidence Dossier What is established Oropouche fever (OF) is an emerging arboviral disease caused by the Oropouche virus (OROV), primarily transmitted by the biting midge Culicoides paraensis. Historically endemic in parts of South and Central America, OROV activity surged across the Americas in 2024,…

Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 18, Status: Authorised

Evidence Dossier: Vocabria (Cabotegravir) – HIV Treatment What is established Vocabria, containing the active substance cabotegravir, is an anti-HIV medication authorized in the European Union since December 2020. It is prescribed alongside rilpivirine to treat adults and adolescents (12 years and older, weighting at least 35 kg) living with controlled human immunodeficiency…

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Date of authorisation: 02/04/2019, Revision: 17, Status: Authorised

What is established Idacio is a biosimilar medicine containing the active substance adalimumab, authorized for use in the European Union since April 2019. Adalimumab is a monoclonal antibody that targets tumor necrosis factor (TNF), a key molecule involved in inflammatory processes. Idacio is used to treat multiple autoimmune and inflammatory conditions including…

Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised

Evidence Dossier: Hemlibra for Hemophilia A – European Medicines Agency Assessment What is established Hemlibra (emicizumab) is a medicine authorised in the European Union for preventing or reducing bleeding episodes in patients with haemophilia A, an inherited bleeding disorder caused by deficient or absent factor VIII. It is approved for: Patients with…

Egypt: Drop Charges Against Prominent Journalist

Egypt: Charges Against Independent Journalist and Press Freedom Concerns What is established On October 22, 2026, Lina Attalah, editor-in-chief of the independent Egyptian media outlet Mada Masr, was formally referred for trial on charges of establishing and managing a website without a license. This development came after prosecutors questioned her over allegations…

U.S. Court Sentences Lender to 15 Years over $76M Ponzi Scheme

What is established On October 27, 2026, a U.S. federal court sentenced Edwin Brant Frost IV to 15 years in prison for orchestrating a Ponzi scheme that defrauded over 300 investors of more than $76 million. Frost was the founder of First Liberty Building and Loan, LLC, a lending firm based in…

Breast cancer treatment: When less is more

Breast Cancer Treatment: When Less is More – Evidence Dossier Source: PLOS Medicine, October 26, 2026, article by Katarzyna Starowicz on behalf of the PLOS Medicine Staff Editors What is Established Breast cancer mortality has declined annually by approximately 2% to 2.5% over the past decade in many high-income countries, largely due…